VistaGen Therapeutics Inc.

(NASDAQ:VTGN)

Collapse Summary General Information
 Location South San Francisco, Calif.
 Region San Francisco Bay Area
 Country U.S.
 Business Category ADMET, Gene/Cell therapy, Neurology
 Year Founded 1998
 Website http://www.vistagen.com
 Lead Product Status Phase II
Get a free BioCentury trial today
 Archive Items are loading loading
 Financial Information
 
 Earnings Summary
 Stocks Annual Chart
Week of 01/19/2018 - 3,589,767 Week of 01/12/2018 - 6,121,047 Week of 01/05/2018 - 7,883,296 Week of 12/29/2017 - 3,260,628 Week of 12/22/2017 - 3,712,777 Week of 12/15/2017 - 9,546,608 Week of 12/08/2017 - 61,494,429 Week of 12/01/2017 - 935,670 Week of 11/17/2017 - 479,954 Week of 11/10/2017 - 901,209 Week of 11/03/2017 - 699,036 Week of 10/27/2017 - 6,407,806 Week of 07/14/2017 - 492,255 Week of 03/31/2017 - 609,254
 Pipeline Information
 
 Deals Information